LV12375A - 1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urinvielas piemerotas ka HIV proteazes inhibitori - Google Patents

1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urinvielas piemerotas ka HIV proteazes inhibitori

Info

Publication number
LV12375A
LV12375A LV990076A LV990076A LV12375A LV 12375 A LV12375 A LV 12375A LV 990076 A LV990076 A LV 990076A LV 990076 A LV990076 A LV 990076A LV 12375 A LV12375 A LV 12375A
Authority
LV
Latvia
Prior art keywords
hiv protease
aminoindazol
phenylmethyl
protease inhibitors
compounds
Prior art date
Application number
LV990076A
Other languages
English (en)
Other versions
LV12375B (lv
Inventor
James David Rodgers
Robert Frank Kaltenbach Iii
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of LV12375A publication Critical patent/LV12375A/lv
Publication of LV12375B publication Critical patent/LV12375B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
LVP-99-76A 1996-11-08 1999-04-29 1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urīnvielas piemērotas kā hiv proteāzes inhibitori LV12375B (lv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2974596P 1996-11-08 1996-11-08
US74710496A 1996-11-08 1996-11-08
PCT/US1997/020035 WO1998020008A1 (en) 1996-11-08 1997-11-04 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors

Publications (2)

Publication Number Publication Date
LV12375A true LV12375A (lv) 1999-11-20
LV12375B LV12375B (lv) 2000-04-20

Family

ID=26705293

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-99-76A LV12375B (lv) 1996-11-08 1999-04-29 1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urīnvielas piemērotas kā hiv proteāzes inhibitori

Country Status (21)

Country Link
EP (1) EP0937067B1 (lv)
JP (1) JP2001503428A (lv)
KR (1) KR20000053122A (lv)
CN (1) CN1235602A (lv)
AT (1) ATE244714T1 (lv)
AU (1) AU5165198A (lv)
BR (1) BR9712910A (lv)
CA (1) CA2270966A1 (lv)
CZ (1) CZ157599A3 (lv)
DE (1) DE69723456T2 (lv)
EA (1) EA199900452A1 (lv)
EE (1) EE9900188A (lv)
ES (1) ES2202645T3 (lv)
HU (1) HUP9904676A2 (lv)
IL (1) IL129727A0 (lv)
LV (1) LV12375B (lv)
NO (1) NO992228L (lv)
PL (1) PL333421A1 (lv)
SI (1) SI20074A (lv)
SK (1) SK59699A3 (lv)
WO (1) WO1998020008A1 (lv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6870098A (en) * 1997-03-31 1998-10-22 Du Pont Merck Pharmaceutical Company, The Indazoles of cyclic ureas useful as hiv protease inhibitors
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
PT1981851E (pt) 2006-01-31 2012-04-13 Array Biopharma Inc Inibidores de cinase e processos para a sua utilização

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas

Also Published As

Publication number Publication date
EP0937067A1 (en) 1999-08-25
SK59699A3 (en) 1999-12-10
EE9900188A (et) 1999-12-15
EA199900452A1 (ru) 2000-02-28
NO992228L (no) 1999-06-07
KR20000053122A (ko) 2000-08-25
CA2270966A1 (en) 1998-05-14
EP0937067B1 (en) 2003-07-09
CZ157599A3 (cs) 1999-11-17
PL333421A1 (en) 1999-12-06
CN1235602A (zh) 1999-11-17
WO1998020008A1 (en) 1998-05-14
ES2202645T3 (es) 2004-04-01
HUP9904676A2 (hu) 2000-06-28
BR9712910A (pt) 2000-03-21
AU5165198A (en) 1998-05-29
DE69723456T2 (de) 2004-05-27
IL129727A0 (en) 2000-02-29
SI20074A (sl) 2000-04-30
LV12375B (lv) 2000-04-20
JP2001503428A (ja) 2001-03-13
NO992228D0 (no) 1999-05-07
ATE244714T1 (de) 2003-07-15
DE69723456D1 (de) 2003-08-14

Similar Documents

Publication Publication Date Title
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
EA200000298A1 (ru) Агонисты простагландинов и их применение для лечения заболеваний костей
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
BR9908004A (pt) Composto, composição e método para prevençãoou supressão de uma infecção viral
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
DK1465626T3 (da) Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf
EA200200471A1 (ru) Конденсированные нафтиридины в качестве ингибиторов обратной транскриптазы вич
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
ES2151600T3 (es) Derivados de n-(3-amino-2-hidroxibutil)sulfonamida utilizados como inhibidores de proteasa de vih.
EA200400690A1 (ru) Нуклеозиды, их препараты и их применение в качестве ингибиторов вирусных рнк-полимераз
BR9813719A (pt) Agentes terapêuticos
YU62504A (sh) Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
ATE223376T1 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
TR200003065T2 (tr) Nöraminidazların inhibitörleri olarak pirolidinler.
LV12375A (lv) 1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urinvielas piemerotas ka HIV proteazes inhibitori
EA200000522A1 (ru) 5-htагонисты
SE9904128D0 (sv) Novel compounds
LT2003003A (en) Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
EA200600560A1 (ru) Ингибиторы проникновения вируса вич